首页 > 市场调查报告书 > 製药

DDS

市场调查报告书

商品编码

1267725

超级崩解剂全球市场研究报告-2023-2030 年行业分析、规模、份额、增长、趋势和预测

Global Superdisintegrants Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030

出版日期: 2023年04月01日 | 出版商:

Value Market Research | 英文 133 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

超级崩解剂是一种赋形剂，一种添加的惰性物质，有助于药物的製造、加工和给药。超级崩解剂用于改善片剂和胶囊在胃肠道中的崩解，这是药物被吸收并有效分布到全身所必需的。超级崩解剂在水分存在下会迅速膨胀和分解，从而为水分进入片剂和胶囊并迅速崩解创造途径。这提高了药物的生物利用度和功效，因为它被更快、更有效地吸收了。常用的超级崩解剂包括交联羧甲基纤维素、羟基乙酸淀粉钠和交联羧甲基纤维素钠。这些赋形剂通常与其他赋形剂（如粘合剂和润滑剂）结合形成完整的片剂或胶囊剂。

市场动态

ODT 是一种快速崩解的片剂，无需水即可在口中溶解。它在老年人和儿童等传统药片吞嚥困难的患者中越来越受欢迎。超级崩解剂是ODT的主要成分，随着对该产品的需求增加，对超级崩解剂的需求也在增加。受社会老龄化、慢性病流行、新兴国家医疗保健服务加强等因素影响，全球医药行业有望呈现高增长态势。超级分散剂是许多药物配方中的重要成分，随着药物需求的增加，对超级分散剂的需求也在增加。患者依从性是患者按规定服药的意愿和能力。超降解剂可以提高药物给药和吸收的便利性，特别是对于吞嚥片剂和胶囊有困难的患者。随着医疗保健提供者和製药公司关注患者的依从性，预计对超降解剂的需求将会增加。仿製药的兴起也推动了对超级分散剂的需求。许多仿製药製造商正在尝试开发可与原研品牌相媲美的製剂，而超级崩解剂可用于提高仿製药产品的性能。超级集成商领域的研究和开发仍在继续，正在开发更新、更有效的产品。这就是为什么製药行业越来越多地采用这些产品，尤其是用于 ODT 和其他快速崩解製剂。

这份研究报告解释了波特的五力模型、市场吸引力分析和价值链分析。这些工具可帮助您清楚地了解您的行业结构并评估您在全球范围内的竞争吸引力。此外，这些工具还提供了对全球超分散剂市场各个部分的全面评估。超分散剂行业的发展和趋势为这项研究提供了一种整体方法。

市场细分

本部分提供有关国家/地区级别细分的详细数据，以帮助战略制定者确定每种产品/服务的目标受众和未来商机。.

按类型

天生的超级整合者
合成表面活性剂
其他超级崩解剂

按处方

平板设备
胶囊

按治疗领域

消化系统疾病
神经系统疾病
肿瘤学
感染
心血管疾病
血液病
炎症性疾病

区域分析

本节对北美、欧洲、亚太地区、拉丁美洲、中东和非洲超级崩解剂市场当前和未来的需求进行了区域展望。此外，它还侧重于所有主要地区每个单独应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的综合概况和全球竞争格局的详细视图。超级崩解剂市场的主要参与者是 BASF SE、Ashland Global Holding Inc.、DowDuPont、Roquette Freres、DFE Pharma、JRS Pharma、Asahi Kasei Corporation、Merck KGaA、Corel Pharma Chem、Avantor Performance Materials。本节包括对竞争格局的全面了解，包括各种战略发展，例如主要併购、未来能力、合作伙伴关係、财务概览、合作、新产品开发和新产品发布。

如果您有任何定制要求，请写信给我们。我们的研究团队可以根据您的需要提供定制报告。

内容

第一章前言

报告内容
- 目的
- 目标受众
- USP（独特的销售建议）及其提供的内容
调查范围
调查方法
- 市场调研流程
- 市场研究方法

第 2 章执行摘要

市场亮点
全球市场概况

第 3 章超级崩解剂 - 行业分析

简介 - 市场动态
市场驱动力
市场製约因素
机会
行业趋势
波特的五力分析
市场吸引力分析
- 按类型进行市场吸引力分析
- 按配方进行市场吸引力分析
- 按治疗领域进行市场吸引力分析
- 市场吸引力分析：按地区

第四章价值链分析

价值链分析
原材料分析
- 原材料清单
- 原材料製造商列表
- 主要原材料价格走势
潜在买家名单
营销渠道
- 直接营销
- 间接营销
- 市场发展趋势

第 5 章超级崩解剂的全球市场分析：按类型

按类型概述
过去和未来的数据
按类型分析
天生的超级整合者
合成表面活性剂（超级崩解剂
其他超级崩解剂

第 6 章超级崩解剂的全球市场分析：按配方分类

剂型概述
过去和未来的数据
按剂型分析
平板设备
胶囊

第 7 章超级崩解剂的全球市场分析：按治疗领域分类

按治疗领域概述
过去和未来的数据
按治疗领域分析
消化系统疾病
神经系统疾病
肿瘤学
感染
心血管疾病
血液病
炎症性疾病

第 8 章超级崩解剂的全球市场分析：按地区

区域展望
介绍
北美销售分析
- 概览、销售业绩和预测分析
- 北美各部门的销售分析
- 北美销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、销售业绩和预测分析
- 按细分市场进行的欧洲销售分析
- 按国家/地区划分的欧洲销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 意大利销售分析
- 俄罗斯销售分析
- 其他欧洲销售分析
亚太地区销售分析
- 概览、销售业绩和预测分析
- 亚太地区各部门的销售分析
- 亚太国家/地区销售分析
- 中国销售分析
- 印度销售分析
- 日本的销售分析
- 韩国销售分析
- 澳大利亚销售分析
- 其他亚太地区销售分析
拉丁美洲销售分析
- 概览、销售业绩和预测分析
- 拉丁美洲各部门的销售分析
- 拉丁美洲国家/地区的销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利的销售分析
- 其他拉丁美洲销售分析
中东和非洲销售分析
- 概览、销售业绩和预测分析
- 中东和非洲各细分市场的销售额分析
- 中东和非洲国家/地区的销售分析
- 沙特阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 其他中东和非洲销售分析

第 9 章：超分散剂公司的竞争形势

超级崩解剂市场竞争激烈
伙伴关係/协作/协议
併购
新产品发布
其他扩展

第十章公司简介

公司股票分析
市场集中度
巴斯夫欧洲公司
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
亚甚兰全球控股公司
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
陶氏杜邦公司
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
Roquette Freres
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
DFE 製药公司
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
JRS 製药
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
旭化成公司
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
默克公司
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
Corel 製药化学
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势
Ava□□ntor 高性能材料
- 公司概况
- 企业收入
- 产品介绍
- 近期趋势

注意：在公司简介、财务细节、近期发展等方面，基于可用信息，私人控股公司可能不包括在内。

简介目录图表

Product Code: VMR112110821

The global demand for Superdisintegrants Market is presumed to reach the market size of nearly USD XX MN by 2030 from USD XX MN in 2022 with a CAGR of XX% under the study period 2023 - 2030.

Superdisintegrants are a type of excipient, which are inactive substances that are added to medications to aid in their manufacture, processing, and administration. Superdisintegrants are used to improve the disintegration of tablets and capsules in the gastrointestinal tract, which is necessary for the medication to be absorbed and effectively distributed throughout the body. Superdisintegrants work by rapidly swelling and breaking apart in the presence of moisture, which helps to create channels for water to enter the tablet or capsule, leading to its rapid disintegration. This improves the bioavailability and efficacy of the medication, as it allows for more rapid and efficient absorption. Commonly used superdisintegrants include cross-linked carboxymethyl cellulose, sodium starch glycolate, and croscarmellose sodium. These excipients are often combined with other excipients, such as binders and lubricants, to form a complete tablet or capsule formulation.

Market Dynamics

ODTs are rapidly disintegrating tablets that dissolve in the mouth without the need for water. They are increasingly popular for patients who have difficulty swallowing conventional tablets, such as the elderly and children. Superdisintegrants are a key ingredient in ODTs, and as demand for these products increases, so too does the demand for superdisintegrants. The global pharmaceutical industry is expected to showcase high growth due to factors such as aging population growth, the prevalence of chronic diseases, and the increasing availability of healthcare services in emerging markets. Superdisintegrants are a critical ingredient in many pharmaceutical formulations, and as the demand for medications increases, so does the demand for superdisintegrants. Patient compliance refers to a patient's willingness and ability to take medications as prescribed. Superdisintegrants can improve the ease of administration and absorption of medications, particularly for patients who have difficulty swallowing tablets or capsules. As healthcare providers and pharmaceutical companies focus more on patient compliance, the demand for superdisintegrants is expected to increase. The increasing availability of generic medications is driving the demand for superdisintegrants. Many generic manufacturers are looking to develop formulations that are equivalent to the brand-name product, and superdisintegrants can be used to improve the performance of the generic product. There has been ongoing research and development in the area of superdisintegrants, resulting in the development of newer and more effective products. This has led to increased adoption of these products in the pharmaceutical industry, particularly for use in ODTs and other rapidly disintegrating formulations.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of superdisintegrants. The growth and trends of superdisintegrants industry provide a holistic approach to this study.

Market Segmentation

This section of the superdisintegrants market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Natural Superdisintegrants
Synthetic Superdisintegrants
Other Superdisintegrants

By Formulation

Tablets
Capsules

By Therapeutic Area

Gastrointestinal Diseases
Neurological Diseases
Oncology
Infectious Diseases
Cardiovascular Diseases
Hematological Diseases
Inflmmatory Diseases

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Superdisintegrants market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the superdisintegrants market include BASF SE, Ashland Global Holding Inc., DowDuPont, Roquette Freres, DFE Pharma, JRS Pharma, Asahi Kasei Corporation, Merck KGaA, Corel Pharma Chem, Avantor Performance Materials. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . SUPERDISINTEGRANTS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Formulation
- 3.7.3 Market Attractiveness Analysis By Therapeutic Area
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL SUPERDISINTEGRANTS MARKET ANALYSIS BY TYPE

5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Natural Superdisintegrants Historic and Forecast Sales by Regions
5.5 Synthetic Superdisintegrants Historic and Forecast Sales by Regions
5.6 Other Superdisintegrants Historic and Forecast Sales by Regions

6 . GLOBAL SUPERDISINTEGRANTS MARKET ANALYSIS BY FORMULATION

6.1 Overview by Formulation
6.2 Historical and Forecast Data
6.3 Analysis by Formulation
6.4 Tablets Historic and Forecast Sales by Regions
6.5 Capsules Historic and Forecast Sales by Regions

7 . GLOBAL SUPERDISINTEGRANTS MARKET ANALYSIS BY THERAPEUTIC AREA

7.1 Overview by Therapeutic Area
7.2 Historical and Forecast Data
7.3 Analysis by Therapeutic Area
7.4 Gastrointestinal Diseases Historic and Forecast Sales by Regions
7.5 Neurological Diseases Historic and Forecast Sales by Regions
7.6 Oncology Historic and Forecast Sales by Regions
7.7 Infectious Diseases Historic and Forecast Sales by Regions
7.8 Cardiovascular Diseases Historic and Forecast Sales by Regions
7.9 Hematological Diseases Historic and Forecast Sales by Regions
7.10. Inflmmatory Diseases Historic and Forecast Sales by Regions

8 . GLOBAL SUPERDISINTEGRANTS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE SUPERDISINTEGRANTS COMPANIES

9.1. Superdisintegrants Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF SUPERDISINTEGRANTS INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. BASF SE
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Ashland Global Holding Inc.
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. DowDuPont
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. Roquette Freres
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. DFE Pharma
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. JRS Pharma
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. Asahi Kasei Corporation
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Merck KGaA
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Corel Pharma Chem
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Avantor Performance Materials
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

简介目录图表